Stay updated on Pembrolizumab in Untreated Extensive SCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Untreated Extensive SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Untreated Extensive SCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2, and a government funding/operating status notice and the earlier Revision: v3.4.1 were removed; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T10:20:52.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding lapse and NIH operating status. Updated the page to version v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:13:30.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Minor UI and metadata updates: glossary display option added and footer text updated to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', replacing the previous labels.
    Difference
    0.2%
    Check dated 2026-01-28T04:48:42.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:12:37.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.
    Difference
    0.1%
    Check dated 2025-12-23T10:36:20.000Z thumbnail image
  9. Check
    105 days ago
    Change Detected
    Summary
    Footer revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T21:25:34.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Untreated Extensive SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Untreated Extensive SCLC Clinical Trial page.